Antibiotic Treatment for Infected Pilonidal Cysts in Diabetic Patients

Primary Antibiotic Choice

The standard dosing for clindamycin is 300-450 mg orally three to four times daily for 7-10 days, as recommended by the American College of Physicians, for treating skin and soft tissue infections caused by susceptible staphylococci, streptococci, and anaerobes 1, 2

Trimethoprim-sulfamethoxazole (160-800 mg orally twice daily) provides good gram-positive coverage, including MRSA, and is an alternative option for penicillin-allergic patients, as suggested by the Infectious Diseases Society of America 3, 4
Doxycycline (100 mg orally twice daily after 200 mg loading dose on day 1) is another option for penicillin-allergic patients, with a strength of evidence rated as moderate, according to the Centers for Disease Control and Prevention 4
Levofloxacin or moxifloxacin (levofloxacin 750 mg daily or moxifloxacin 400 mg daily) offer broad-spectrum coverage, with a high strength of evidence, as recommended by the European Society of Clinical Microbiology and Infectious Diseases 3, 4

Optimize glycemic control aggressively, as hyperglycemia significantly impairs infection eradication and wound healing in diabetic patients, with a high strength of evidence, according to the American Diabetes Association 2
Monitor clinical response every 2-5 days initially for outpatients, assessing for resolution of local inflammation, systemic symptoms, and purulent drainage, as recommended by the Infectious Diseases Society of America, with a moderate strength of evidence 5, 6, 7

Antibiotics should be used for a defined period based on the clinical infection, not for the entire time the wound remains open, with a high strength of evidence, as suggested by the Surgical Infection Society 5, 6

Treat for 7-10 days for uncomplicated infections with surrounding cellulitis, as recommended by the American College of Physicians, with a moderate strength of evidence 2
Extend to 14 days if there is extensive cellulitis or slow clinical response, with a low strength of evidence, according to the Infectious Diseases Society of America 2

Do not use cephalosporins in patients with immediate (anaphylactic-type) penicillin reactions due to up to 10% cross-reactivity risk, with a high strength of evidence, as warned by the American Academy of Allergy, Asthma, and Immunology 4, 1
Avoid tetracyclines as primary therapy for pilonidal infections due to limited effectiveness against major pathogens, with a moderate strength of evidence, according to the European Society of Clinical Microbiology and Infectious Diseases 1
Do not rely on antibiotics alone without addressing the need for surgical drainage or excision, with a high strength of evidence, as recommended by the Surgical Infection Society 5, 6